• Alfuzosin HCl: Mechanism and BPH Research

  2026-09-08

  Alfuzosin HCl is a functionally uroselective α1 adrenoceptor antagonist that reduces prostate, bladder-neck, and urethral smooth-muscle tone in benign prostatic hyperplasia. Its clinical pharmacology, formulation parameters, solubility, and assay ranges support both translational and analytical BPH research.

• Annexin V-APC/7-AAD Apoptosis Kit: Read Death in Context

  2026-09-08

  The Annexin V-APC/7-AAD Apoptosis Kit converts phosphatidylserine exposure and membrane failure into an interpretable cell-death map. This article connects the assay to PAD4–NET cancer research while defining what apoptosis detection can—and cannot—prove.

• Fasting, Translatome Remodeling, and Tumorigenesis

  2026-09-07

  Yang et al. identify phosphorylation of eIF4E as a selective translational control mechanism that enables hepatic ketogenesis during fasting and ketogenic feeding. The study connects fatty-acid sensing through the AMPK–MNK–eIF4E pathway to diet-dependent pancreatic tumor growth, providing a mechanistic basis for combining dietary intervention with translational inhibition.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-09-07

  Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal rod disc membranes, preserving proteoform-specific interaction information. The study shows that lipid modifications and proteoform identity influence rhodopsin-associated assemblies and the off-target binding of vardenafil and sildenafil to PDE6, providing a framework for more discriminating drug-screening assays.

• Temozolomide: Mechanism-Led Glioma Assays

  2026-09-05

  Temozolomide is a small-molecule alkylating agent for DNA damage, DNA repair mechanism research, and glioma models. This article develops a genotype-aware assay strategy based on ATRX status, combination design, and rigorous interpretation of chemotherapy resistance data.

• 5-Azacytidine Reprograms Dormant Cells to Block Metastasis

  2026-09-04

  Singh et al. show that 5-Azacytidine combined with retinoic acid agonism can reprogram disseminated cancer cells into a stable, non-proliferative state rather than merely eliminating them. The study links metastasis suppression to restoration of TGF-β–SMAD4 signaling and provides a framework for evaluating epigenetic control of cancer dormancy.

• N4-Acetylcytidine: From Structure to Strategy

  2026-09-04

  A mechanistic and translational guide to using N4-Acetylcytidine as a defined ac4C nucleoside substrate, analytical reference, and control in RNA epigenetics research.

• Taihangia rupestris: UPLC-MS/MS and Bioactivity

  2026-09-03

  This 2026 RSC Advances study combines UPLC-MS/MS profiling, complementary antioxidant tests, α-glucosidase inhibition, activity-guided screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest chemical and functional profile, supporting conservation-oriented cultivation while identifying flavonoids and phenolics as priorities for further natural-product research.

• GS-441524: Designing Matrix-Aware Antiviral Assays

  2026-09-03

  GS-441524 research is most informative when parent compound, released nucleoside, and downstream active metabolite are measured together. This article develops a matrix-aware assay strategy from recent LC–MS/MS evidence, with practical guidance for antiviral and pharmacokinetic studies.

• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-09-02

  The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein formed the most favorable and dynamically stable computational complexes, but biochemical and cellular validation remains necessary before interpreting them as antiviral inhibitors.

• IDH2 Reprogramming Drives CRC Through HIF-1α

  2026-09-02

  The reference study identifies mitochondrial IDH2 as a metabolic driver of colorectal cancer progression, linking reductive TCA cycle activity to ATP production, glycolysis, and HIF-1α signaling. Its combined genetic, pharmacological, cellular, and in vivo evidence suggests that IDH2-dependent α-ketoglutarate handling is a potential metabolic vulnerability, while also defining experiments needed to separate energy failure from direct control of HIF-1α turnover.

• Aβ42 Fibrils Activate Microglial Phagocytosis

  2026-09-01

  Kopec and Carroll showed that fibrillar Amyloid β-Peptide (1-42) stimulates murine microglial phagocytosis in a time- and dose-dependent manner. Their multi-cargo flow-cytometry design linked Aβ42 aggregation state, persistence after peptide removal, and proteoglycan-dependent regulation to a broader model of amyloid-driven innate immune activation.

• Otilonium Bromide: Applied Research Workflows

  2026-09-01

  Otilonium Bromide provides a practical antimuscarinic perturbation tool for cholinergic signaling, smooth muscle contractility, and receptor-mediated cellular assays. This workflow-focused guide covers stock preparation, controls, concentration planning, troubleshooting, and responsible translation of structure-based screening concepts.

• Abiraterone Acetate in 3D Prostate Models

  2026-08-31

  Build more informative prostate cancer research assays by pairing CYP17 inhibition with patient-derived three-dimensional spheroids. This workflow emphasizes compound identity, exposure control, orthogonal readouts, and troubleshooting when organ-confined models show limited response.

• Superoxide Dismutase Activity Assay Kit

  2026-08-31

  The Superoxide Dismutase (SOD) Activity Assay Kit K2035 provides a colorimetric way to quantify functional SOD activity in biological fluids through inhibition of WST-1 formazan formation. It is intended for research assays and oxidative stress workflows, not for diagnosis, clinical decisions, or direct measurement of every reactive oxygen species.

7996 records 5/534 page Previous Next 12345 下5页 Last page